Preparing for change & workable solutions & clarifying complexity & poachers turned gamekeepers & different perspectives & shaping the rules & that’s Regulatory & Administrative with Bird & Bird
Our Regulatory & Administrative Practice helps domestic and international businesses, banks, financial institutions and a wide range of other organisations achieve maximum benefit from their dealings with regulatory bodies and national, regional or local governments.
We advise on cutting edge regulatory and competition issues, from the perspectives of universal service providers and other, new entrant operators.
We can also help you prepare for regulatory changes, manage your relationships with regulators and, where possible, help you to achieve regulatory change or clarification. We advise on licensing issues; business strategy in the light of regulatory requirements; and the approaches of regulatory authorities, both at EU level and at national levels across Europe and Asia. We represent clients as defendants, complainants or interveners in regulatory and competition regulatory investigations by EU and national authorities.
Our approach, whilst founded on an in-depth understanding of the legal and regulatory landscape, has a strongly practical and commercial focus. We give clear explanations of complex issues, robustly promote and defend your interests and add value wherever possible to your business.
We provide expertise in the following:
The Bill of the Law on the organization and transformation of the French healthcare system at the French parliament, adoption of the final version is expected for the end of July.
Lawrence Freeman (Senior Counsel, Bird & Bird, Brussels and previously the European Counsel of Tesla, Inc.) reviews the new European vehicle CO2 emissions performance standards and the opportunities for manufacturers of ...
Bird & Bird, together with consultancy firm Ecorys, has produced a study on behalf of the European Commission on "The implementation of the open internet provisions of the Telecoms Single Market Regulation".
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes
International law firm Bird & Bird is advising Norwegian company Infront ASA ('Infront') on its acquisition of German company vwd Group GmbH and its European subsidiaries. The current majority shareholder, US private ...
There are no forthcoming events for this area. Please click on the button below to view past events.
How have you used data to transform your business? We caught up with our speakers Andrew Radley, BD Director at… https://t.co/XqTWqw3Ily
Are you part of the Bird & Bird alumni community? Our exclusive alumni platform is now available in Italy, which co… https://t.co/D0Cgg5z0uV